<DOC>
	<DOCNO>NCT01793142</DOCNO>
	<brief_summary>This survey conduct prepare application material examination Pharmaceutical Affairs Laws Enforcement Regulation , assess safety efficacy profile VIVIANT usual practice accord Re-examination Regulation New Drugs</brief_summary>
	<brief_title>Post Marketing Surveillance For General Drug Use To Assess Safety And Efficacy Profile Of Viviant In Usual Practice</brief_title>
	<detailed_description>continuous enrollment</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Postmenopausal osteoporosis osteopenia patient Patients active past history venous thromboembolic event include deep vein thrombosis , Patients pulmonary embolism retinal vein thrombosis</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>SERM</keyword>
</DOC>